2022-04-012023-03-312023-03-31false07546371NEW ACCESS (EAST ANGLIA) LIMITED2023-11-2046460iso4217:GBPxbrli:pure075463712022-04-01075463712023-03-31075463712022-04-012023-03-31075463712021-04-01075463712022-03-31075463712021-04-012022-03-3107546371bus:SmallEntities2022-04-012023-03-3107546371bus:AuditExempt-NoAccountantsReport2022-04-012023-03-3107546371bus:FullAccounts2022-04-012023-03-3107546371bus:PrivateLimitedCompanyLtd2022-04-012023-03-3107546371core:WithinOneYear2023-03-3107546371core:AfterOneYear2023-03-3107546371core:WithinOneYear2022-03-3107546371core:AfterOneYear2022-03-3107546371core:ShareCapital2023-03-3107546371core:SharePremium2023-03-3107546371core:RevaluationReserve2023-03-3107546371core:OtherReservesSubtotal2023-03-3107546371core:RetainedEarningsAccumulatedLosses2023-03-3107546371core:ShareCapital2022-03-3107546371core:SharePremium2022-03-3107546371core:RevaluationReserve2022-03-3107546371core:OtherReservesSubtotal2022-03-3107546371core:RetainedEarningsAccumulatedLosses2022-03-3107546371core:LandBuildings2023-03-3107546371core:PlantMachinery2023-03-3107546371core:Vehicles2023-03-3107546371core:FurnitureFittings2023-03-3107546371core:OfficeEquipment2023-03-3107546371core:NetGoodwill2023-03-3107546371core:IntangibleAssetsOtherThanGoodwill2023-03-3107546371core:ListedExchangeTraded2023-03-3107546371core:UnlistedNon-exchangeTraded2023-03-3107546371core:LandBuildings2022-03-3107546371core:PlantMachinery2022-03-3107546371core:Vehicles2022-03-3107546371core:FurnitureFittings2022-03-3107546371core:OfficeEquipment2022-03-3107546371core:NetGoodwill2022-03-3107546371core:IntangibleAssetsOtherThanGoodwill2022-03-3107546371core:ListedExchangeTraded2022-03-3107546371core:UnlistedNon-exchangeTraded2022-03-3107546371core:LandBuildings2022-04-012023-03-3107546371core:PlantMachinery2022-04-012023-03-3107546371core:Vehicles2022-04-012023-03-3107546371core:FurnitureFittings2022-04-012023-03-3107546371core:OfficeEquipment2022-04-012023-03-3107546371core:NetGoodwill2022-04-012023-03-3107546371core:IntangibleAssetsOtherThanGoodwill2022-04-012023-03-3107546371core:ListedExchangeTraded2022-04-012023-03-3107546371core:UnlistedNon-exchangeTraded2022-04-012023-03-3107546371core:MoreThanFiveYears2022-04-012023-03-3107546371core:Non-currentFinancialInstruments2023-03-3107546371core:Non-currentFinancialInstruments2022-03-3107546371dpl:CostSales2022-04-012023-03-3107546371dpl:DistributionCosts2022-04-012023-03-3107546371core:LandBuildings2022-04-012023-03-3107546371core:PlantMachinery2022-04-012023-03-3107546371core:Vehicles2022-04-012023-03-3107546371core:FurnitureFittings2022-04-012023-03-3107546371core:OfficeEquipment2022-04-012023-03-3107546371dpl:AdministrativeExpenses2022-04-012023-03-3107546371core:NetGoodwill2022-04-012023-03-3107546371core:IntangibleAssetsOtherThanGoodwill2022-04-012023-03-3107546371dpl:GroupUndertakings2022-04-012023-03-3107546371dpl:ParticipatingInterests2022-04-012023-03-3107546371dpl:GroupUndertakingscore:ListedExchangeTraded2022-04-012023-03-3107546371core:ListedExchangeTraded2022-04-012023-03-3107546371dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-04-012023-03-3107546371core:UnlistedNon-exchangeTraded2022-04-012023-03-3107546371dpl:CostSales2021-04-012022-03-3107546371dpl:DistributionCosts2021-04-012022-03-3107546371core:LandBuildings2021-04-012022-03-3107546371core:PlantMachinery2021-04-012022-03-3107546371core:Vehicles2021-04-012022-03-3107546371core:FurnitureFittings2021-04-012022-03-3107546371core:OfficeEquipment2021-04-012022-03-3107546371dpl:AdministrativeExpenses2021-04-012022-03-3107546371core:NetGoodwill2021-04-012022-03-3107546371core:IntangibleAssetsOtherThanGoodwill2021-04-012022-03-3107546371dpl:GroupUndertakings2021-04-012022-03-3107546371dpl:ParticipatingInterests2021-04-012022-03-3107546371dpl:GroupUndertakingscore:ListedExchangeTraded2021-04-012022-03-3107546371core:ListedExchangeTraded2021-04-012022-03-3107546371dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2021-04-012022-03-3107546371core:UnlistedNon-exchangeTraded2021-04-012022-03-3107546371core:NetGoodwill2023-03-3107546371core:IntangibleAssetsOtherThanGoodwill2023-03-3107546371core:LandBuildings2023-03-3107546371core:PlantMachinery2023-03-3107546371core:Vehicles2023-03-3107546371core:FurnitureFittings2023-03-3107546371core:OfficeEquipment2023-03-3107546371core:AfterOneYear2023-03-3107546371core:WithinOneYear2023-03-3107546371core:ListedExchangeTraded2023-03-3107546371core:UnlistedNon-exchangeTraded2023-03-3107546371core:ShareCapital2023-03-3107546371core:SharePremium2023-03-3107546371core:RevaluationReserve2023-03-3107546371core:OtherReservesSubtotal2023-03-3107546371core:RetainedEarningsAccumulatedLosses2023-03-3107546371core:NetGoodwill2022-03-3107546371core:IntangibleAssetsOtherThanGoodwill2022-03-3107546371core:LandBuildings2022-03-3107546371core:PlantMachinery2022-03-3107546371core:Vehicles2022-03-3107546371core:FurnitureFittings2022-03-3107546371core:OfficeEquipment2022-03-3107546371core:AfterOneYear2022-03-3107546371core:WithinOneYear2022-03-3107546371core:ListedExchangeTraded2022-03-3107546371core:UnlistedNon-exchangeTraded2022-03-3107546371core:ShareCapital2022-03-3107546371core:SharePremium2022-03-3107546371core:RevaluationReserve2022-03-3107546371core:OtherReservesSubtotal2022-03-3107546371core:RetainedEarningsAccumulatedLosses2022-03-3107546371core:NetGoodwill2021-04-0107546371core:IntangibleAssetsOtherThanGoodwill2021-04-0107546371core:LandBuildings2021-04-0107546371core:PlantMachinery2021-04-0107546371core:Vehicles2021-04-0107546371core:FurnitureFittings2021-04-0107546371core:OfficeEquipment2021-04-0107546371core:AfterOneYear2021-04-0107546371core:WithinOneYear2021-04-0107546371core:ListedExchangeTraded2021-04-0107546371core:UnlistedNon-exchangeTraded2021-04-0107546371core:ShareCapital2021-04-0107546371core:SharePremium2021-04-0107546371core:RevaluationReserve2021-04-0107546371core:OtherReservesSubtotal2021-04-0107546371core:RetainedEarningsAccumulatedLosses2021-04-0107546371core:AfterOneYear2022-04-012023-03-3107546371core:WithinOneYear2022-04-012023-03-3107546371core:Non-currentFinancialInstrumentscore:CostValuation2022-04-012023-03-3107546371core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-04-012023-03-3107546371core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-04-012023-03-3107546371core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-04-012023-03-3107546371core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-04-012023-03-3107546371core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-04-012023-03-3107546371core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-04-012023-03-3107546371core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-04-012023-03-3107546371core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-04-012023-03-3107546371core:Non-currentFinancialInstrumentscore:CostValuation2023-03-3107546371core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-03-3107546371core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-03-3107546371core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-03-3107546371core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-03-3107546371core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-03-3107546371core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-03-3107546371core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-03-3107546371core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-03-3107546371core:Non-currentFinancialInstrumentscore:CostValuation2022-03-3107546371core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-03-3107546371core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-03-3107546371core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-03-3107546371core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-03-3107546371core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-03-3107546371core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-03-3107546371core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-03-3107546371core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-03-3107546371bus:Director12022-04-012023-03-3107546371bus:Director22022-04-012023-03-31

NEW ACCESS (EAST ANGLIA) LIMITED

Registered Number
07546371
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2023

NEW ACCESS (EAST ANGLIA) LIMITED
Company Information
for the year from 1 April 2022 to 31 March 2023

Directors

O'CONNOR, Curtis Luke
O'CONNOR, Glen George

Registered Address

Box Pharmacy 10 High Street
Box
Corsham
SN13 8NN

Registered Number

07546371 (England and Wales)
NEW ACCESS (EAST ANGLIA) LIMITED
Balance Sheet as at
31 March 2023

Notes

2023

2022

£

£

£

£

Fixed assets
Investments61,974,6151,804,259
1,974,6151,804,259
Current assets
Debtors9-151,893
Cash at bank and on hand5,6195,529
5,619157,422
Creditors amounts falling due within one year10(436,915)(746,063)
Net current assets (liabilities)(431,296)(588,641)
Total assets less current liabilities1,543,3191,215,618
Creditors amounts falling due after one year11(1,191,122)(1,206,710)
Net assets352,1978,908
Capital and reserves
Called up share capital1010
Profit and loss account352,1878,898
Shareholders' funds352,1978,908
The financial statements were approved and authorised for issue by the Board of Directors on 20 November 2023, and are signed on its behalf by:
O'CONNOR, Curtis Luke
Director
O'CONNOR, Glen George
Director

Registered Company No. 07546371
NEW ACCESS (EAST ANGLIA) LIMITED
Notes to the Financial Statements
for the year ended 31 March 2023

1.Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
2.Compliance with applicable reporting framework
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
3.Basis of measurement used in financial statements
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
4.Accounting policies
Functional and presentation currency policy
The financial statements are presented in sterling and this is the functional currency of the company.
Taxation policy
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. Current or deferred taxation assets and liabilities are not discounted. Current tax is recognized at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.
Investments policy
Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Listed investments are measured at fair value where the difference between cost and fair value is material. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.
5.Employee information

20232022
Average number of employees during the year00
6.Fixed asset investments

Investments in groups1

Total

££
Cost or valuation
At 01 April 221,804,2591,804,259
Additions170,356170,356
At 31 March 231,974,6151,974,615
Net book value
At 31 March 231,974,6151,974,615
At 31 March 221,804,2591,804,259

Notes

1Investments in group undertakings and participating interests
7.Description of nature of transactions and balances with related parties
At the year-end, amounts owed by/to group undertakings balance include Nil (2022: £369,694 Dr) due to Coralberry Limited and £83,582 (2022: 151,893 Dr) due to Frampton Pharmacy Limited, where Mr. Curtis L O'Connor and Mr. George G O'Connor are also directors of those companies.
8.Directors advances, credits and guarantees
Included in other creditors is an amount of £286,314 (2022: £260,273 Cr) relates to the directors' loan account Mr. George G O'Connor. Included in other creditors is an amount of Nil (2022: £15,017 Cr) relates to the directors' loan account Mr. Curtis O'Connor.
9.Debtors

2023

2022

££
Amounts owed by group undertakings-151,893
Total-151,893
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
10.Creditors within one year

2023

2022

££
Bank borrowings and overdrafts64,74194,838
Amounts owed to related parties83,582369,694
Taxation and social security1194,412
Other creditors286,314275,290
Accrued liabilities and deferred income2,1591,829
Total436,915746,063
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
11.Creditors after one year

2023

2022

££
Bank borrowings and overdrafts1,191,1221,206,710
Total1,191,1221,206,710